Pharma Journalist - Page 37 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Adcytherix Secures €105M Series A to Advance Cancer Drug Pipeline

Minovia Therapeutics Wins FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

Viatris Acquires Aculys Pharma to Expand CNS Portfolio in Japan

Avantor Partners with BlueWhale Bio to Accelerate CAR-T Therapy Manufacturing

Johnson & Johnson to Spin Off Orthopaedics Unit as Standalone Company ‘DePuy Synthes’

BioCryst to Acquire Astria Therapeutics in $700M Deal to Strengthen HAE Pipeline

Nabla Bio and Takeda Expand AI Drug Discovery Deal Worth Over $1B

Pfizer’s TUKYSA Shows Strong Results in First-Line HER2+ Breast Cancer Trial

Jacobio Sells 80% Stake in Cardiovascular Subsidiary to Oceanpine for RMB 200M

SystImmune Begins Global Trial for Iza-Bren in Breast Cancer, Triggers $250M Milestone from BMS